Alexey Ryazanov

Dr. Ryazanov is a Professor of Pharmacology at Rutgers University and a biochemist and molecular biologist whose discovery of alpha-kinases, a class of protein kinases that include elongation factor-2 kinase (eEF2K) and channel-kinasesTRPM6 and TRPM, is the foundation for Longevica’s research approach. Dr. Ryazanov led Longevica’s groundbreaking 3.5 year study which led to the discovery of three high-performing classes of compounds that showed a statistically significant life extension effect of 16-22%. Dr. Ryazanov is a pioneer in the longevity science field, a leading researcher in the field of protein synthesis and magnesium, the recipient of +$20M in NIH research grants, and holds 10 US patents.